J. Lu, Z. Zhao, L. Pan, H. Wu, S. Wang, X. Tong, S. Wu: Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets. In: Molecular Biomedicine. Band 6, Nummer 1, Juli 2025, S. 50, doi:10.1186/s43556-025-00299-y
Martin Barsch, B. Buhren, Peter Arne Gerber: Ästhetische Behandlungen mit Fillern und das Management von Nebenwirkungen. In: Aktuelle Dermatologie. 2017, Band 43, Nummer 10, S. 399–407. doi:10.1055/s-0043-115198.
Michael F. Meyer, Günther Kreil, H.N. Aschauer: The soluble hyaluronidase from bull testes is a fragment of the membrane‐bound PH‐20 enzyme. In: FEBS Letters. 1997, Band 413, Nummer 2, S. 385–388. doi:10.1016/s0014-5793(97)00936-8.
Graham Cohen, Corlia Coetzee, Christopher Walton, Òscar Reig, Byoung Chul Cho, Georgina McAdam, Carlos A. Rojas, L.M. Rodriguez, Zsuzsanna Pápai, Sze Wai Chan, Bernardo L. Rapoport, Christian Caglevic, Patricio Yañez Weber, Toshiaki Takahashi, Takayasu Kurata, Gina Song, Julia W. Cohen, Omobolaji O. Akala, Richard Khanyile: Pharmacokinetics and Bioavailability of Pembrolizumab With Berahyaluronidase Alfa for Subcutaneous Administration in Participants With Advanced or Metastatic Solid Tumors: The Phase 1 Study 3475A-C18. In: European Journal of Cancer. 2025, S. 115709. doi:10.1016/j.ejca.2025.115709.